Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression'. Together they form a unique fingerprint.

Medicine & Life Sciences